About SANO Diagnostics
SANO Diagnostics is a company based in Wellesley (United States) founded in 2013 by Paul Hayre. SANO Diagnostics offers products and services including Diagnostic Technology and Data Management Services. SANO Diagnostics operates in a competitive market with competitors including HYCOR BioMedical, Exagen, Lophius Biosciences, PredictImmune and Immudex, among others.
- Headquarter Wellesley, United States
- Founders Paul Hayre
- SectorsHealthcare
- Website sanodx.com
- Social LinkedIn
- Legal Name Sano Diagnostics Llc
- Latest Funding Round$50K (USD), Grant
Oct 2014
- Investors
Products & Services of SANO Diagnostics
SANO Diagnostics offers a comprehensive portfolio of products and services, including Diagnostic Technology and Data Management Services.
Tools for early detection of inflammation to aid clinical decisions
Solutions for managing and analyzing diagnostic information
Funding Insights of SANO Diagnostics
- Total Rounds 1
- Last Round Grant — $50,000
- First Round $50,000
(Oct 2014)
- Investors Count 1
All 1 funding rounds of SANO Diagnostics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2014 | $50,000 | Grant | – | – |
1 investors in total: 1 institutional.
Investors in SANO Diagnostics
SANO Diagnostics has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include MassChallenge.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage entrepreneurs are accelerated through MassChallenge's program. | – | masschallenge.org | Boston, United States |
Investor details for SANO Diagnostics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of SANO Diagnostics
2 people are tracked at SANO Diagnostics (2 in leadership).
| Name | Role | Group |
|---|---|---|
Paul Hayre | Co-Founder & President | Leadership |
Barry J Wolfenson | CEO | Leadership |
Complete people profiles for SANO Diagnostics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of SANO Diagnostics
2 dated milestones of SANO Diagnostics across 1 years, from founding to its latest funding, stage changes and deals.
- Founded SANO Diagnostics is founded.
- Funding First funding round of $50K.
Competitors of SANO Diagnostics
SANO Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as HYCOR BioMedical, Exagen, Lophius Biosciences, PredictImmune and Immudex, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| hycorbiomedical.com | 1981 | Garden Grove, United States | $99.57M | – | Developer of diagnostic instruments and reagents for autoimmune diseases and allergies | |
| exagen.com | 2002 | Vista, United States | $110.23M | 204 | Diagnostic and monitoring solutions for autoimmune connective diseases are developed. | |
| lophius.com | 2008 | Regensburg, Germany | $23.73M | 28 | T-cell-based diagnostics for infectious and immune diseases are developed. | |
| predictimmune.com | 2017 | Cambridge, United Kingdom | $18.32M | 15 | Tools for diagnosing immune-mediated inflammatory diseases are developed. | |
| immudex.com | 2009 | Copenhagen, Denmark | $16.35M | 42 | Provider of immune monitoring reagents and services for research and clinical use | |
| kypha.net | 2009 | Saint Louis, United States | $16.76M | – | Diagnostic biomarker tests for inflammation and autoimmune diseases are developed. | |
| cellidx.com | 2012 | San Diego, United States | $1.34M | 7 | Immunodiagnostic reagents for immunohistochemistry are manufactured and marketed. | |
| smarthealthdx.com | 1979 | Irvine, United States | $17.29M | – | Precision diagnostics for vascular, metabolic, and oncological diseases are developed. | |
| protagen.com | 1997 | Dortmund, Germany | $19.84M | 20 | Autoantibody biomarkers are utilized for autoimmune disease diagnostics. | |
| celsense.com | 2005 | Pittsburgh, United States | $7.11M | 2 | Develops MRI agents for tracking transplanted cells in medical applications. |
Detailed competitors of SANO Diagnostics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to SANO Diagnostics
10 companies that operate in the same segment as SANO Diagnostics (Immunology & Cancer Therapeutics), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Antibody-based drugs are developed for autoimmune diseases and cancer treatment. | 2008 | Ghent, East Flanders, Belgium | USD 61.9 M | USD 1.41 B | 355 | |
Targeted and immune-oncology drugs for cancer treatment are developed. | 2010 | Cambridge, Massachusetts, United States | USD 172 M | – | – | |
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 | |
Targeted therapies for cancer treatment are developed. | 2005 | Waltham, Massachusetts, United States | USD 198.29 M | USD 172.35 M | 270 | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Plasma-based biologics are developed for immune deficiency and infectious diseases. | 2005 | Ramsey, Minnesota, United States | USD 17.55 M | USD 510.17 M | 685 | |
Antibody drugs for cancer treatment are developed. | 2015 | Singapore, Singapore | USD 150 M | – | – | |
CAR T-cell and T-cell receptor immunotherapies for cancer are developed. | 2013 | Seattle, Washington, United States | USD 316.67 M | – | 520 | |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | 2003 | United States | USD 171.85 M | USD 102.48 M | 338 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about SANO Diagnostics
SANO Diagnostics was founded in 2013 and raised its 1st funding round 1 year after it was founded.
SANO Diagnostics is headquartered in Wellesley, United States. It is registered at Wellesley, Massachusetts, United States.
Barry J Wolfenson is the current CEO of SANO Diagnostics.
Sano Diagnostics was founded in 2013 and is headquartered in Wellesley, United States. The company operates in the healthcare diagnostics sector, where a point-of-care platform is developed to assess chronic wounds such as diabetic foot ulcers and pressure ulcers. Wound protease-related biochemistry is measured, and markers of inflammation are detected, enabling clinicians to evaluate patient wound status and progression through biochemical insights.
SANO Diagnostics's top competitors include Exagen, SmartHealth and HYCOR BioMedical.
SANO Diagnostics offers Diagnostic Technology and Data Management Services.
SANO Diagnostics has 1 investor. Key investors include MassChallenge.
SANO Diagnostics operates through Sano Diagnostics Llc.